RESEARCH INTO THE PATHOPHYSIOLOGY OF STROKE in man has been limited by the lack of accurate, non-invasive techniques for measuring regional cerebral blood flow and metabolism. The development of positron emission tomography (PET) has made it practical to study the local hemodynamic and metabolic changes that occur in human subjects with cerebrovascular disease. Although still in a state of rapid technological and methodological development, PET has already provided important new data about the pathophysiology of stroke and promises to be of even greater value in the future. This article will review the current status of PET for the study of cerebrovascular disease in man. A basic understanding of the advantages and limitations of this technique is necessary to properly interpret these studies. Therefore, we will first briefly discuss some technical and methodologic aspects of PET making specific comments about their importance in the study of cerebrovascular disease. Further details about these aspects of PET can be obtained from recently published reviews.
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Methodology In order to apply PET to the study of cerebral physiology, three things are necessary: (1) a positron emission tomograph for accurate measurement of regional radioactivity in vivo, (2) a positron-emitting radiotracer suitable for human use and (3) a mathematical model of radiotracer kinetics that quantitatively relates regional radioactivity measured by PET to the physiologic variable under study.
Positron Emission Tomography
The use of radioactive molecules as tracers to investigate biological function is well established. All quantitative radiotracer methods depend on accurate measurement of tracer radioactivity in tissue or in body fluids. Such measurements are easily accomplished in vitro by a variety of techniques including scintillation counting and autoradiography. Quantitative measurements of regional radioactivity in vivo using external detectors present much more formidable difficulties ( fig. 1 A) . Only a fraction of the photons emitted from the radioactive source ever reach the external detector. Other photons undergo interactions within the tissue that result in loss of energy. Some are then absorbed by the tissue while others undergo a change in direction (Compton scattering) and may interact with an adjacent detector. The twin problems of absorption and scattering make it very difficult to perform accurate quantitative measurement of regional radioactivity with conventional external detector systems (such as the Anger camera used in clinical nuclear medicine).
Positron emission tomography can minimize these problems by taking advantage of the physical properties of positrons. Certain radionuclides decay by emission of a positron, a small particle with the same mass as an electron but the opposite charge. After traveling a few millimeters through tissue the positron comes to rest and interacts with an electron, resulting in the destruction of both. This annihilation event creates two gamma photons that travel away from the annihilation site in opposite directions. A pair of external detectors positioned on either side of a positron-emitting source will register these photons at almost the same instant ( fig. IB) . If the detector pair is connected by an electronic coincidence circuit that records a signal only when two photons arrive almost simultaneously, then only photons arising from positron annihilations occurring between the detector pair will be recorded. 3 Most scattered annihilation photons will not be recorded because there will be no photon striking the opposite detector coincidently. In this way, the use of coincidence detection minimizes the contribution of scattered photons. However, in order to achieve accurate quantitation, some correction also must be made for the loss of radioactivity due to scatter and absorption by surrounding tissue. This correction can be performed with an external positron-emitting source as shown in figure 1C .
A positron emission tomograph consists of a large number of detector pairs connected by coincidence circuits. After correction for losses due to absorption and scatter the information obtained from these detector pairs is used to construct a series of projections, each representing the distribution of regional radioactivity as viewed from a different angle. These projections are then combined to produce a two-dimensional reconstruction of the regional radioactivity within the STROKE VOL 16, No 3, MAY-JUNE 1985 detectors' field. 4 Tomographs with multiple rings of detectors can generate multiple reconstructed slices simultaneously, each depicting a different area of the brain. This reconstructed image is an accurate, quantitative representation of regional tissue radioactivity. 5 In contrast, single photon emission computed tomography (SPECT) uses data from a large array of unpaired detectors for similar image reconstruction. Accurate, quantitative measurement of regional radioactivity with SPECT is not possible because the process is still subject to the shortcomings of single detector systems. Scattered radiation degrades the image and the correction for losses due to scatter and absorption cannot be performed accurately. 6 Positron emission tomographs capable of accurate, quantitative measurements of regional radioactivity in vivo have been built utilizing a variety of designs. Discussion of the engineering and performance characteristics of these different machines is not the purpose of this article, but several aspects pertinent to their use are worth considering. Approximately one million coincidence events per tomographic slice must be collected in order to provide a reconstructed image with acceptable ( < 5%) statistical error. 7 The rate at which coincidence events can be collected accurately will determine the necessary scanning time. This rate varies for different scanner designs and can place important limitations on the type of investigations that can be performed with each machine.
A second, and perhaps the most important, aspect of tomograph design concerns the effect of image resolution on quantitation of regional radioactivity. In the PET image, radioactivity from a given region is redistributed or smeared over a larger area. The amount of smearing determines the resolution of the scanner. As a consequence of this redistribution, a given region in the reconstructed image, regardless of its size, contains only a portion of the radioactivity actually within that region in the original structure. The remainder has been redistributed into surrounding areas of the image. Similarly, some radioactivity originally in these surrounding regions has been redistributed into the region of interest. Thus, the regional radioactivity measurement made with PET represents some portion of the radioactivity actually within that region plus a contribution from radioactivity in surrounding regions. 8 " 10 This is known as partial volume averaging. The effect of partial volume averaging on regional quantitation depends on both the resolution of the scanner and the distribution of radioactivity. Areas of low radioactivity surrounded by areas of high radioactivity are particularly difficult to measure accurately. As a result of the partial volume effect, it is difficult to obtain measurements that truly represent either pure gray matter or pure white matter (except perhaps in the centrum semiovale). This is especially true for cortical regions which will always contain a heterogeneous mixture of cortical gray matter and contiguous subcortical white matter. Furthermore, any superficial cortical region will also include some cerebrospinal fluid within the cortical sulci. Inclusion of this metabolically inactive fluid leads to underestimation of regional brain measurements. Inaccuracies in the measurement of regional radioactivity due to partial volume averaging can be reduced by scanner designs that improve the resolution of the reconstructed image.
Positron Emitting Radiotracers
The second requirement for PET is a radiotracer containing a positron-emitting radionuclide. For radiotracer applications, positron-emitting radionuclides can be divided into two groups -radioisotopes of elements that are normal constitutents of biological molecules ("C, I3 N, 15 O) or radioisotopes of non-biologic elements that can be attached to biologic molecules as radiolabels ( I8 F, 68 Ga, 75 Br). These positron emitting radionuclides have half-lives ranging from 2 minutes to 2 hours. This allows relatively large amounts of radioactivity to be administered while keeping the radiation dose to the subject at a safe level. Since the radioactivity decays rapidly, sequential studies are easily performed. The disadvantage of these short-lived radionuclides is obvious. In most cases, they must be prepared on site or shipped only short distances. Since production of the more commonly used positron emitters ("C, I3 N,
I5
O and I8 F) requires a cyclotron or linear accelerator, their availability is currently quite restricted.
Synthesis of molecules incorporating short-lived radionuclides is a specialized field requiring great expertise. The synthesis must be performed rapidly and, at the same time, yield substances that are of sufficient purity to be safe for administration to human subjects. Several reviews dealing with this field have been recently published."" 13 
Tracer Methods and Models
The third requirement for PET is a mathematical model that quantitatively relates tissue concentration of the positron-emitting radionuclide (as measured by the tomograph) to the physiologic variable under study. This model must take into account a variety of factors including delivery of the tracer to the tissue, distribution and metabolism of the tracer within the tissue, recirculation of metabolized and unmetabolized tracer and the amount of tracer remaining in the blood. Furthermore, the model must be practically applicable given the constraints imposed by current tomographic designs and the amount of radioactivity that can be safely administered to human subjects. The following sections deal with some of the more widely used methods for measuring regional cerebral blood flow (rCBF), regional cerebral blood volume (rCBV), the regional cerebral metabolic rate for oxygen (rCMRO 2 ), and the regional cerebral metabolic rate for glucose (rCMRGlu). The advantages and disadvantages of each method, particularly with respect to its use in the study of cerebrovascular disease, are discussed.
Cerebral Blood Flow
While variety of methods for measuring rCBF have been proposed, 2 most studies of patients with cerebrovascular disease have been performed with techniques that rely on 15 O-H 2 O as a flow tracer. These techniques are subject to error because the blood-brain barrier is not completely permeable to water. 1415 As a result, 15 O-H 2 O is incompletely extracted from the blood when flow is high with consequent underestimation of rCBF. The most widely used method for measuring rCBF with PET involves the continuous inhalation of l5 O-labeled carbon dioxide. 2 ' l6 " 19 In the pulmonary vessels, 15 O-CO 2 is rapidly converted to water by carbonic anhydrase in red blood cells. The result 15 O-H 2 O circulates throughout the body. After five to ten minutes, a steady state in the brain is reached such that the amount of radioactivity entering as I5 O-H 2 O is equal to the amount lost by radioactive decay and venous outflow. Regional CBF can then be calculated if the arterial blood radioactivity is known. Although never independently validated by direct comparison with another method for measuring rCBF, this steady-state technique gives values for rCBF that are comparable to those obtained with other methods and that vary appropriately with changes in arterial carbon dioxide concentration. 20 -2I This method has many practical advantages. First, its use is not limited by machine design. Scanning can be carried out as long as necessary (typically five minutes) to provide enough counts for statistical accuracy. Second, only a single arterial blood sample needs to be collected during steady state conditions, although in practice several are usually obtained. The major disadvantages of the steady-state I5 O-CO 2 method stem from the non-linear relationship between regional radioactivity and rCBF. This has two consequences. First, inaccuracies in measurement of brain or blood radioactivity in or in the value assumed for the blood-brain partition coefficient for water (k) cause errors in rCBF that become progressively larger as the blood flow increases.
722 " 24 Second, in any region containing a mixture of cerebral tissues with different blood flows, the measured rCBF will deviate by up to 30% from the true mean value for rCBF in that STROKE VOL 16, No 3, MAY-JUNE 1985 region. This deviation will also increase at higher flows. 25 In ischemic or infarcted tissue where rCBF is low, the effect of measurement errors, alterations in A. and incomplete permeability of H 2 O will be minimized. However, inaccuracies will still occur where CBF is heterogeneous such as the area surrounding an infarct. When rCBF is high due to reperfusion hyperemia or luxury perfusion, all errors will be magnified. Normal values obtained with this technique for regions containing a mixture of cortical gray and subcortical white matter have been reported as 39.3 ± 5.8 ml/(min-100 ml) (mean ± standard deviation). 26 An alternative method for measuring rCBF with 15 O-H 2 O is based on the classic tissue autoradiographic technique of Kety and co-workers. 27 -28 This method utilizes a bolus intravenous injection of 15 O-H 2 O followed by a 40 second PET scan. Implementation of this technique is restricted to tomographs that can accurately collect a large number of counts in such a short period. This technique has been validated in baboons by comparison with rCBF values determined by direct intracarotid injection of I5 O-H 2 O. Because of the almost linear relationship between regional radioactivity and rCBF present with this model, the measured regional rCBF closely approximates the weighted mean CBF for tissues within the region. Errors in the estimation of X also have very little effect on the measured CBF. The major disadvantage of the modified, autoradiographic technique is its dependence on the arterial time-activity curve. This curve, obtained by sequential sampling from a peripheral artery, is assumed to be the same as that for the cerebral arteries. Any difference between the peripheral arterial curve and the cerebral arterial curve will lead to errors in calculated rCBF. This problem can largely be overcome by timing the arrival of the radiotracer bolus in the brain and shifting the peripheral curve to match. The modified, autoradiographic method therefore provides an accurate means for measuring rCBF at low to normal flow rates that is unaffected by the inevitable presence of tissue heterogeneity. 29 30 The mean normal value obtained in our laboratory with this technique is 48.4 ± 7.8 ml/(min-100 g).
Cerebral Blood Volume
Measurement of rCBV is performed following inhalation of air containing trace amounts of carbon monoxide labeled with either "C or 15 O. The labeled carbon monoxide binds to hemoglobin in red blood cells and circulates throughout the body. When equilibrium between arterial and venous circulations is reached, the regional radioactivity in the brain will be equal to the amount of labeled carboxyhemoglobin and therefore proportional to the regional red cell mass. By measuring the amount of radioactivity in a peripheral blood sample and correcting for the difference between the peripheral, large vessel hematocrit and the mean hematocrit of cerebral microvessels, the intraparenchymal cerebral blood volume can be determined. 31 " 33 The principle source of error in this measurement stems from the use of a single standard value as the correction factor for the difference between peripheral (or large vessel) and the tissue (or small vessel) hematocrit. 34 Recent evidence indicates that there are not only regional differences in cerebral hematocrit, but that the regional cerebral hematocrit may change from one physiologic state to another. 35 Under these circumstances, use of a single correction factor would lead to errors in the estimation of rCBV. The normal value for rCBV in our laboratory is 5.1 ± 1.1 ml/100 g.
Regional CBV data can be used to correct other PET measurements for the amount of radiotracer remaining within the intravascular space. This correction is extremely important for measurements of oxygen metabolism, as discussed below. In addition, rCBV provides an index of local vasodilation which is of value as an indicator of local reduction in tissue perfusion pressure. An increase in CBV in response to a fall in cerebral perfusion pressure has been a consistent finding in experimental studies.
3637

Metabolism
Under normal circumstances, the brain depends almost exclusively on the oxidative metabolism of glucose to supply its energy needs. Studies of cerebral metabolism with PET have therefore concentrated on measuring the metabolic rates for these two substrates. Determinations of cerebral oxygen metabolism have generally included calculation of the local fractional extraction of oxygen from the blood (regional oxygen extraction fraction or rOEF). Direct measurements of cerebral arteriovenous oxygen differences during global ischemia have shown that OEF rises when CBF falls, thus helping to maintain CMRO 2 . 38 An increase in rOEF may therefore serve as an indicator of imbalance between blood supply and tissue demand for oxygen. Conversely, a normal or low rOEF should indicate adequate tissue oxygen delivery. This latter interpretation may not be valid under pathological conditions, however. Disturbances in cerebral oxidative metabolism during ischemia and reperfusion occur in a microheterogeneous pattern. 39 Studies performed in rats subjected to systemic hypotension and hypercapnea have shown that severe derangements in cerebral energy metabolism can occur while whole brain OEF remains normal, presumably due to such microscopic inhomogeneities in perfusion. 40 ' 41 Since these inhomogeneities are well below the resolution capabilities of PET, a normal or low rOEF measured by PET does not insure that cellular oxygenation is adequate at all sites within the region.
Cerebral oxygen consumption is most commonly measured by an extension of the steady state I5 O-CO 2 inhalation method. 16 20 The PET method consistently overestimated rOEF. This error is caused by failure to correct for radioactivity from intravascular I5 O-O 2 still bound to hemoglobin. The resultant overestimation of rOEF depends upon the local intravascular volume and is greatest at low values of rOEF and rCBF. 24 42 The error varies from 5 to 20% in normal subjects but may be as high as 50% in patients with acute cerebral infarction. 43 The calculated rCMRO 2 will be similarly overestimated, although the final error in this measurement will be further influenced by the inaccuracies in the determination of rCBF discussed earlier. 24 Correction for the effect of intravascular I3 O-O 2 hemoglobin can be performed by using data from a separately performed rCBV measurement. 42 26 Normal values for rOEF of gray matter corrected for rCBV have recently been reported as 0.37 ± 0.04. 43 Mintun and his colleagues recently have described a method for measuring rOEF and rCMRO 2 with single breath inhalation of air containing 15 O-O 2 followed by a 40 second PET scan. 31 As with the modified autoradiographic method for measuring rCBF, this method is also limited to tomographs capable of performing accurately at high counting rates. Data from separately performed 15 O-H 2 O CBF and I5 O-CO CBV studies are also required. The accuracy of this method has been verified by comparison with the direct intracarotid injection of 15 O-O 2 in baboons. Errors in the measurement of rCBF or rCBV cause errors of similar magnitude in rOEF and rCMRO 2 when rCMR0 2 is normal or elevated. However, when rCMRO 2 is below 2 ml per min-100 g, the effect of measurement errors in CBF and CBV is magnified several fold. 31 Thus, this method can be expected to be less accurate when applied to areas of cerebral infarction with reduced rCMRO 2 . Normal values in our laboratory are 0.37 ± 0.09 for rOEF and 2.87 ± 0.46 ml/(min-100 g) for rCMRO 2 .
Measurements of glucose metabolism with PET have relied heavily on modifications of the l4 C-deoxyglucose ( I4 C-DG) autoradiographic method as originally described by Sokoloff and his colleagues. 45 This method is based on the fact that deoxyglucose is transported into the brain and phosphorylated in a manner similar to glucose, but is then not further metabolized and remains trapped in the tissue. The metabolic rate for glucose was expressed by Sokoloff et al in terms of 3 rate constants (RC) describing the influx, efflux and phosphorylation of deoxyglucose plus a lumped constant (LC) that corrected for the difference between the kinetics of glucose and deoxyglucose. The I4 C-DG method has been adapted to PET using l8 F-deoxyglucose ( I8 F-DG) as the radiotracer. 4^48 RC for I8 F-DG (including a fourth rate constant describing the dephosphorylation of l8 F-DG-6-phosphate) for normal human subjects have been determined by sequential scanning. 47 - 48 By using the average value for each RC determined from these experiments, the value of LC necessary to make the calculated global CMRGlu equal to a mean literature value of 5.38 mg per min-100 g was determined.
47 -** These average values for RC and LC, together with a single PET scan performed 45 48 Substantial differences in the estimation of rCMRGlu occur when normal RC or averaged "ischemia" RC are used in place of the individually measured RC in patients with cerebrovascular disease. 50 " 52 Therefore, in order to insure maximum accuracy in the measurement of rCMRGlu with 18 F-DG in patients with cerebrovascular disease, RC must be measured individually. The LC presents a more difficult problem. Its value for ischemic or infarcted tissue in human brain remains completely unknown. Hawkins et al have presented a theoretical analysis of the factors involved, and have concluded that the LC should have a similar value in both normal and ischemic tissue. 50 However, when Ginsberg and Reivich measured LC for I4 C-DG during cerebral ischemia in cats, they found that it increased more than two fold. 53 Since the LC is in the denominator of the Sokoloff equations, such an increase would result in a decrease in rCMRGlu values of greater than 50% as compared with those calculated with the normal LC. Therefore, even when RC are measured individually, uncertainty about the value of the LC makes the deoxyglucose method of dubious value for the quantitative measurement of rCMRGlu in ischemic or infarcted brain. 54 -55 Normal values for rCMRGlu in cortical regions in man obtained with I8 F-DG range from 6.5-8.5 mg/ (min-100 g). 56 Because of the problems inherent in the I8 F-DG method, several laboratories are investigating the possibility of measuring glucose metabolism directly using "C-glucose. 57 -M Vyska and colleagues have used another glucose analog, 3-("C)-methyl-D-glucose, to study glucose kinetics in man. The distribution of 3-("C)-methyl-D-glucose is dependent upon the relationship of forward and reverse transport across the blood-brain barrier as well as the local blood flow. Because methyl-glucose is not metabolized, quantitative measurements of rCMRGlu are not possible with this method. quantitative, physiologic measurements is an exacting and often difficult task. As a result, experimental results are sometimes reported in terms of regional radioactivity only (expressed as PET counts). Interpretation of such studies is difficult. If the relationship between PET counts and the physiologic measurements is relatively linear (CBV measurements, autoradiographic CBF method), regional variations in PET counts will accurately reflect regional physiologic variations. Therefore, valid conclusions regarding changes in one part of the brain relative to another can be made. However, without quantitative conversion, there will be no way to determine the true physiologic significance of these findings ( fig. 2) true physiologic measurements, comparison of regional differences between subjects is often rendered difficult by individual variations. These variations may be truly physiologic or may be due to the methodologic errors already discussed. As a result of such variations, an area where CBF is clearly decreased relative to the rest of the brain in one subject may have a quantitative value for CBF equal to the area of greatest flow in another subject. In order to account for these variations, regional physiologic measurements are often expressed (or "normalized") relative to the mean whole brain value or the maximum value in each subject. Another similar approach is the use of ratios between homologous regions in each hemisphere. While this sort of approach may make regional changes easier to detect, the information contained in the absolute values of the measurement is lost. Application of this type of analytic strategy to the study of patients with cerebrovascular disease has several disadvantages. Cerebral infarction in one part of the brain can cause decreased CBF and metabolism at distant sites making ratios or normalized values unreliable as quantitative measurements. Furthermore, absolute quantitative values are extremely important when investigating cerebrovascular disease as shown by experiments demonstrating threshold values for CBF below which neuronal dysfunction or membrane failure occur. A final point to consider in analyzing the results obtained with PET is the interpretation of differences that occur from study to study or from subject to subject. Both whole brain and regional changes in CBF, CBV and metabolism are observed in normal subjects who are restudied under similar, standardized conditions ( fig. 4) . These changes represent a combination of measurement errors, small changes in head position, normal physiologic variability and differences in the underlying state of both conscious and subconscious cerebral activity. Changes in blood flow or metabolism that occur from study to study must therefore be interpreted with caution. For example, a change that occurs with sensory stimulation may be due to specific activation of cerebral structures by that stimulus but might also reflect changes in mood, vigilance or thought content of the subject. 65 Similar cautions are necessary in ascribing cause and effect to any changes seen following therapeutic interventions. Only those changes that are consistently reproducible and of statistical significance when compared with appropriate controls should be accepted. It is only when these criteria have been fulfilled that valid conclusions regarding pathophysiology can be drawn.
PET Studies of Cerebrovascular Disease in Man Transient Ischemic Attacks
The pathogenesis of transient ischemic attacks remains poorly understood. While a variety of clinical observations indicate that platelet-fibrin emboli play a major role, hemodynamic factors also may be important. A local decrease in cerebral perfusion pressure due to stenosis or occlusion of the large arteries supplying the brain, may be the primary cause of TIA in some patients. Alternatively, such large vessel disease may create areas of the brain with poor collateral circulation that are especially vulnerable to platelet emboli. PET provides a method not only to study rCBF in patients with TIA but to determine the physiological consequences of any alterations in cerebral perfusion by providing information about rCBV, rOEF and rCMRO 2 .
Baron and co-workers have reported on three patients with TIA and carotid occlusion. 6667 One had normal brain CT and two had watershed infarcts. PET demonstrated a region of relatively decreased CBF ipsilateral to the carotid occlusion in all three that was outside the area of infarction in the latter two. Regional CMRO 2 in these areas was normal in one case and decreased in two. Regional OEF was normal in one (with decreased rCMRO 2 ) and elevated in the other two. This combination of increased rOEF with decreased rCBF has been termed the "misery-perfusion" syndrome. 66 Whether or not these patients are at increased risk for cerebral infarction due to a decrease in circulatory reserve remains to be determined. 66 " 69 Donnan et al studied ten patients with hemispheric TIA and reported a wide variety of changes in rCBF, rCMRO 2 and rOEF both ipsilaterally and contralaterally. 70 We have investigated a number of patients with TIA as part of a study to assess the hemodynamic and metabolic effects of extracranial-intracranial bypass surgery. Some have had normal rCBF, rCBV, rCMRO 2 and rOEF in spite of severe carotid occlusive disease ( fig. 5 ). We have, however, observed a small group of patients with hemispheric TIA, normal brain CT scan, and ipsilateral carotid occlusion whose PET studies demonstrated a marked decrease in rCBF to the entire territory supplied by the middle cerebral artery. Concomitant with this marked decrease in rCBF, there was a lesser decrease in rCMRO 2 while rCBV and rOEF were both focally increased 7 ' 172 ( fig. 6 ). The minimum values for rCBF and rCMRO 2 in these patients were 22.1 iru7(min-100 g) and 1.43 ml(min-100 g) respectively. Since all these patients were neurologically normal at the time of the PET study, one can conclude that rCBF and rCMRO 2 must be reduced below these levels before cerebral function is compromised. 72 Further evidence to support this conclusion is contained in a recent study of rCBF and rCMRO 2 in 4 patients with subarachnoid hemorrhage who developed hemiparesis in association with cerebral vasospasm. 73 These patients (and a similar patient reported by Baron) 66 appear to constitute a subgroup in whom carotid occlusive disease has caused chronic regional hypoperfu- sion and in whom hemodynamic factors may be important in the pathogenesis of transient cerebral ischemia. Oxygen metabolism is maintained by local compensatory mechanisms that include dilation of intraparenchymal vessels (manifested by increased rCB V) and an increased transfer of oxygen from blood to tissue.
Gibbs et al have studied a group of 32 patients with carotid artery occlusion. 74 " Six had completed strokes, 16 had stroke with subsequent carotid territory TIA, 7 had carotid territory TIA only and 3 had no symptoms in the carotid artery territory. Regional CBV was increased in uninfarcted tissue distal to the occlusion. Regional CBF was matched to the metabolic needs of the tissue (normal rOEF) in 27 of the 32. Regional OEF was elevated only in those five patients with the lowest CBF/CBV ratio. These findings suggest that vasodilation was an early compensatory response to decreased perfusion pressure (in keeping with the concept of autoregulation) 75 and that increased oxygen extraction occurred only under more severe conditions. This interpretation is consistent with previous experimental results.
3 *' 37 We have not, however, been able to confirm the accuracy of the CBF/CBV ratio as a predictor of OEF. 76 Based on these data, it would appear that the following series of events take place as local cerebral perfusion pressure falls ( fig. 7) . Local cerebral blood flow is at first maintained by dilation of pre-capillary resistance vessels. When compensatory vasodilation is maximal, autoregulation fails and cerebral blood flow begins to decline. Local cerebral oxygen metabolism is then maintained by a progressive increase in rOEF. Once rOEF becomes maximal, a further decrease in rCBF will result in a disruption of normal cellular metabolism and function. Whether this disruption is reversible or progresses to irreversible infarction depends on the complicated interplay of a variety of factors, as yet poorly understood. 78 While dilation of precapillary resistance vessels is the most likely explanation for the increase in CBV that accompanies a fall in cerebral perfusion pressure, 3637 certain observations suggest that changes may also take place at the capillary level. Morphological studies of cerebral capillaries in animals subjected to hypoxia have demonstrated a variety of changes including recruitment, dilation and proliferation. 79 " 81 Taken together, these data suggest that the decrease in tissue oxygen supply produced by focal cerebral ischemia may cause a local increase in the intravascular volume of the capillary bed and thereby contribute to the observed increase in rCBV. These capillary changes would facilitate oxygen delivery to brain tissue by decreasing intercapillary distance and increasing capillary surface area. Observations of dilated retinal veins in patients with carotid artery occlusion suggest that there may as well be a venous contribution to the increase in CBV. 82 These studies of transient cerebral ischemia indicate that it is a heterogeneous disorder with variable changes in both cerebral blood flow and metabolism. 
FIGURE 7. Compensatory Responses to Local Cerebral Hypoperfusion. As local cerebral perfusion pressure (CPP) falls, cerebrovascular autoregulation occurs and pre-capillary resistance vessels dilate. This causes an increase in local cerebral blood volume (CBV) while maintaining both local cerebral blood flow (CBF) and metabolic rate of oxygen (CMRO i ). When compensatory vasodilation is maximal, the limit of autoregulation is reached, (B) and a further decrease in local CPP will lead to a fall in CBF. Oxygen extraction fraction OEF then increases to maintain CMR02-When OEF becomes maximal, the limit of compensatory mechanisms (C) has been reached. A further decrease in CBF will put the brain at risk for infarction. Subsequent changes in CBV, OEF and CMROi reflect the complicated metabolic processes that occur in severely ischemic or freshly infarcted tissue and are, as yet, incompletely defined.
different types of TIA according to physiologic criteria and to determine if physiologic measurements are of prognostic value when used in combination with clinical, angiographic and CT findings.
Cerebral Infarction PET studies of patients with stable cerebral infarcts greater than one month old have been in general agreement. The area of the brain corresponding to the infarct on CT scan demonstrates a decrease in both rCBF and rCMRO 2 . Regional OEF is either normal or slightly decreased, suggesting that the blood supply is adequate to meet the oxidative requirements of the residual tissue and that normal coupling of blood flow to metabolism is present. 26 ' **•" • M Regional CBV can be normal or decreased, but is often high relative to rCBF ( fig. 8) these old infarcts is also reported to be decreased. 84 " 86 Kuhl et al found that rCBF and rCMRGlu were equally reduced in old infarcts. 85 Interpretation of these findings must be tempered by knowledge of the quantitative inaccuracies of the deoxyglucose method when applied to ischemic or infarcted tissue, as already discussed.
Acute Ischemic Stroke
Most PET studies of ischemic cerebrovascular disease have been devoted to the study of acute ischemic stroke. 26 ' 446883 ' 87 - 89 The impetus behind this work comes from clinical and experimental evidence demonstrating recovery of cerebral function following variable periods of ischemia. 61 " 64 PET provides a method to study both cerebral hemodynamics and metabolism during the early stages of stroke and to determine if such reversibly ischemic tissue can be identified.
The picture of the evolution of acute cerebral infarction that emerges from these studies is remarkably consistent. During the first few days, both rCMRO 2 and rCBF are decreased, but disproportionately so, such that rOEF is elevated. Within the first week rCMRO 2 remains the same or decreases slightly. Changes in rCBF during the first week are more variable. Flow may increase or decrease but in general becomes higher relative to rCMR0 2 , causing a fall in rOEF. During the second and third weeks, rCBF increases with no concomitant change in rCMRO 2 . As a result, rOEF decreases further. This uncoupling of flow and metabolism fits the definition of luxury perfusion as described by Lassen and colleagues, 88 but occurs at a later time (fig. 2) . The pathophysiological mechanism of this late luxury perfusion is not known, but it is likely to be different from that of early luxury perfusion where local vasodilation due to acid metabolites has been postulated. 90 Finally, rCBF returns to levels that more closely match the metabolic rate of the tissue suggesting that coupling between flow and metabolism has been reestablished (although at a somewhat lower level than normal as evidenced by persistently low values of rOEF in some patients).
The pathophysiological significance of these changes in cerebral blood flow and metabolism is not known. Changes in rCBF bear little relationship either to clinical status or to the metabolic rate of the tissue. Given the dependence of the brain on oxidative metabolism, one might expect rCMRO 2 to be the most important determinant of functional and structural integrity of cerebral tissue. The available data on this point are confusing. Local decreases in rCMRO 2 are the best predictors of ultimate infarction regardless of rOEF or rCBF. 84 On the other hand declines in rCMRO 2 with no clinical worsening and clinical improvement without concomitant increases in rCMR0 2 also occur. 44 The proper interpretation of the early elevation in rOEF remains unclear. Wise and his colleagues have offered the following hypothesis. 44 During the early stages of stroke, mitochondrial function remains intact resulting in an increase in the extraction of oxygen from the residual cerebral blood flow. Regional CMR0 2 , previously determined by the energy requirements of the tissue, becomes dependent on rCBF (the stage of "critical perfusion"). After a variable period of time this precarious state can no longer be maintained. Irreversible infarction occurs with a fall in both rCMRO 2 and rOEF regardless of any further decrease in rCBF. During the stage of critical perfusion, therefore, restoration of blood flow should lead to an increase in oxidative metabolism. These investigators attempted this in one patient who had a persistent elevation of rOEF at day 4. Systemic blood pressure was raised by angiotensin infusion resulting in increased blood flow to the ischemic area. Regional OEF decreased but rCMRO 2 did not change and there was no clinical improvement. 44 Some further insight into the pathophysiologic significance of the rOEF is provided in a recent study by Baron et al correlating early PET findings with later CT evidence of infarction. 88 89 Regardless of rOEF, infarction occurred in areas where rCMRO 2 was less than 1.5 to 1.7 ml/(min-100 g). In fact, those areas of brain with high OEF that went on to infarct had lower values for rCBF and rCMR0 2 than those areas with normal or decreased OEF. As noted earlier, similar increases in rOEF have been observed in patients with TIA. In contrast to patients with TIA in whom rCMRO 2 is maintained at normal or slightly below normal levels, patients with acute stroke demonstrated increased rOEF with markedly decreased rCMRO 2 .
Although an increase in rOEF may serve to maintain cerebral oxygen metabolism at this lower level in acute infarction, its value as a marker for reversible depression of oxidative metabolism following acute stroke remains to be demonstrated.
Very few studies of CBV in acute ischemic stroke have been published. We and others 43 -76 have observed increases in rCBV and decreases in the rCBF/rCBV ratio. Whether these increases reflects autoregulatory vasodilation or neovascularization is not known.
Studies of glucose metabolism during the acute stages of cerebral infarction using I8 F-DG have, in general, shown decreases in rCMRGlu. 50 85 In two patients studied less than two days after acute infarction, rCBF was decreased to a greater degree than rCMRGlu. In three patients studied during the second week, rCBF was increased relative to rCMRGlu. These findings were interpreted as evidence for a transient period of anaerobic glycolysis occurring in the first few days following acute ischemic stroke. Baron et al have reported a low rCMRO 2 /rCMRGlu ratio in the core of two infarcts less than 1 week old (again suggesting anaerobic glycolysis) but found high ratios in the borders of four infarcts less than 12 days old, suggesting utilization of an alternate energy substrate in these areas. 51 Wise and colleagues have studied eight recent, large cerebral infarcts and found a decrease in the rCMRO 2 / rCMRGlu ratio. 55 Since rOEF was also low, they postulated that tissue O 2 delivery was adequate and that these findings were most likely due to infiltrating phagocytic cells that rely mainly on anaerobic glycolysis for their energy demands.
All ot these studies with "t-Uij report a common finding. In the early days following cerebral infarction, rCMRGlu is depressed less than rCBF or rCMRO 2 . This mismatch is interpreted as indicating anaerobic glycolysis. The validity of this interpretation rests on the assumption that the measurements of glucose metabolism are accurate. As noted earlier, the value for the LC in ischemic or infarcted tissue is unknown and it may increase as much as two fold. 53 In this case, the values for CMRGlu reported here (which were calculated using the LC for normal brain) would have to be decreased by more than 50%. Many of these studies would then show a disproportionate decrease in CMRGlu compared to rCBF or rCMRO 2 , suggesting metabolism of an alternate energy substrate.
Syrota and his colleagues have used "C-DMO (5,5-dimefhyl-2,4-oxazolidinedione) to study cerebral acid base status in 9 patients with cerebral infarcts 10-34 days old.
91 DM0 is a weak acid whose ionized form distributes in different tissue compartments according to pH, with higher concentrations occurring at higher pH. These investigators found increased concentrations of "C-DMO in areas of infarction, suggesting an increase in the intracellular pH of remaining viable cells. However, since these findings could also be due to an increase in total or extracellular brain water as well as alterations in brain permeability to DM0 (and hence in partitioning across the blood-brain barrier), the meaning of the observations is not clear.
Distant Effects
A common finding in PET studies of cerebral infarction has been the discovery of areas with decreased CBF or metabolism in structurally normal brain regions distant from the site of infarction. Similar findings have been demonstrated previously in the hemisphere contralateral to cerebral infarction using other techniques to measure CBF. 92 " 95 These findings have been ascribed to a decrease in neuronal activity caused by interruption of the input from afferent fiber pathways, a phenomenon known as diaschisis. 96 In the ipsilateral hemisphere, reductions of rCMRGlu in structurally normal visual cortex of patients with infarction involving the optic radiations anteriorly have been reported by several investigators. 85 -97~100 Similar reductions in CBF and metabolism have been observed at other ipsilateral cortical sites distant from the infarct and in cortex overlying subcortical infarction or hemorrhage.
84 -86 -99 -IOM05 By far the most common area of diaschisis observed in the hemisphere ipsilateral to cerebral infarction has been the thalamus. A decrease in rCMRGlu of this structure in patients with infarction in the middle cerebral artery territory and sparing of the thalamus by CT has been observed by a variety of investigators.
84 -85 -l02 -l03 Similar reductions in rCMRGlu have been seen in the basal ganglia when this region was spared.
85 -86 -l02 Similar decreases in both rCBF and rCMR0 2 with little change in rOEF have also been observed in both thalamus and basal ganglia. 44 -99 Reductions in CBF and metabolism in the hemisphere contralateral to cerebral infarction have been reported for both the homologous cortical area and for the whole hemisphere.
26 -52 - 99 Regional OEF may be normal or decreased. 26 These changes are most pronounced within the first two weeks following infarction. 26 Crossed cerebellar diaschisis was first reported by . 106 - 107 He observed matched depression of rCBF and rCMRO 2 (normal OEF) in the contralateral cerebellar hemisphere of patients with supratentorial infarction less than two months old. These changes were seen only in patients with significant hemipare-STROKE VOL 16, No 3, MAY-JUNE 1985 sis, but were not related to the size of the infarct on CT. Seven patients studied greater than two months post ictus did not show similar changes. Lenzi et al confirmed the presence of this phenomenon and also reported lesser decreases in rCBF and rCMRO 2 in the ipsilateral cerebellar hemisphere of patients with a depressed level of consciousness. 26 In this series, crossed cerebellar diaschisis was not seen with small infarcts and was more pronounced with parietal than frontal lesions. Martin et al have recently reported results from 15 patients. 108 Ten with frontal infarctions showed marked depression of rCMRO 2 and rCBF in the contralateral cerebellar hemisphere with lesser depressions in the ipsilateral cerebellar hemisphere also. Three patients with infarction restricted to the parietooccipital region showed no crossed cerebellar diaschisis but had mild symmetrical depressions in both cerebellar hemispheres. Crossed cerebellar diaschisis was not related to infarct size, neurologic deficit or the time interval since infarction. It was not seen in two patients with unilateral hemispheric decreases in rCBF and rCMRO 2 but no evidence of infarction by CT. Kushner et al found crossed cerebellar diaschisis to be more common with parietal than frontal lesions in a study of 9 patients. One patient was studied at both 3 days and 3 months following a subcortical infarct. Crossed cerebellar diaschisis was present on the initial study but not on the later one. 109 All these reports are in general agreement on the common occurrence of crossed cerebellar diaschisis with hemispheric infarction, but there remains some controversy over the influence of infarct size, location and age.
The occurrence of decreased CBF and metabolism in multiple distant sites following hemispheric infarction is now well established by PET. The best explanation for these findings is local functional depression of neuronal activity due to interruption of afferent or efferent fiber pathways. Regional CBF and metabolism are generally decreased to the same degree 26 "-M ( fig.   9 ), demonstrating the normal coupling of flow and metabolism expected with functional depression. A primary disturbance in cerebrovascular regulation might, on the other hand, be expected to produce mismatched reductions of rCBF and rCMRO 2 with consequent elevation of rOEF. The clinical significance of diaschisis remains unknown. Determination of its relationship, if any, to the development and resolution of neurologic deficits in ischemic stroke will require further study.
Extracranial-Intracranial Bypass Surgery
PET can be used to measure regional hemodynamic and metabolic changes that occur following therapeutic interventions and thus can aid in the evaluation of different treatment modalities. Furthermore, by supplementing currently available clinical and radiographic data with physiologic measurements, PET may also help to define subgroups of patients within otherwise homogeneous populations who may respond to treatment differently. To date, this application of PET has been directed primarily at patients undergoing cerebral revascularization by superficial temporal artery-middle cerebral artery (STA-MCA) bypass anastomosis. Yamamoto et al have reported rCBF measurements in 16 such patients with stroke or TIA. 110 Preoperatively, all had decreased rCBF to the symptomatic hemisphere. Postoperatively, rCBF increased to both cortical and subcortical sites ipsilateral to the anastomosis. However, no improvement in rCBF to areas of old infarction occurred. Baron et al reported results of STA-MCA surgery in five patients: one with TIA, two with cerebral infarction and TIA, and two with stable cerebral infarction. 6667 Preoperatively, all had uninfarcted regions with decreased CBF and two had concomitant increases in rOEF. Following bypass surgery, rCBF improved in four and rOEF returned to normal in the two patients where it had been elevated. One of these showed a slight increase in rCMROj. We have now studied 21 patients undergoing STA-MCA bypass anastomosis. 71 Twelve had TIA, three had cerebral infarction with subsequent TIA, and six had stable cerebral infarction. Following surgery, there was a significant improvement in CBF to the symptomatic operated hemisphere in 6 patients. The preoperative PET studies in these six patients had revealed a large area of uninfarcted brain with decreased CBF in the symptomatic hemisphere. In 5 of the six, CMRO 2 in this hemisphere was also decreased. Hemispheric OEF was increased in 3 and hemispheric CBV was increased in 5. Post-operatively, along with the improvement in CBF to the operated hemisphere indicating, all six patients showed a significant decrease in hemispheric OEF implying that an increase in the local fractional extraction of oxygen had served as a compensatory mechanism to maintain CMRO 2 . There was no significant change in CMRO 2 indicating that the compensation had been adequate. There was also no post-operative change in CBV suggesting that, although the bypass improved blood flow, perfusion pressure was still below the autoregulatory limit and maximal vasodilation was still present ( fig. 7 ). Gibbs et al have reported preliminary data on the results of STA-MCA bypass in their group of patients with carotid occlusion. 75 The predominant effect of the surgery was to decrease rCBV with little change in rCBF. It appears that these patients had not reached the limit of autoregulation pre-operatively. Surgery improved perfusion pressure, reducing the amount of vasodilation necessary to maintain flow.
The number of patients undergoing STA-MCA surgery studied by PET thus far is obviously too small to permit any firm clinical conclusions. There does, however, appear to be a group of patients with decreased rCBF in whom bypass surgery will improve blood flow. Surgery on less severely affected patients seems to result in an improvement in local cerebral perfusion pressure with no change in rCBF. Whether these improvements reduce the subsequent risk of stroke in these patients by improving circulatory reserve remains to be determined. Significant improvements in rCMRO 2 following STA-MCA bypass have not been demonstrated. However, no patient with dramatic clinical improvement of the kind that has been reported following this operation has been studied with PET.
1 "-"
2
Other Cerebrovascular Diseases Bousser et al have reported a 45 year old woman with migrainous cerebral infarction who demonstrated a variety of changes in rCBF and rCMRO 2 distant from the infarct site." 3 Frackowiak and colleagues have shown decreases in both rCBF and rCMRO 2 in nine patients with vascular dementia. No patient showed focal elevation of rOEF, suggesting that ongoing ischemia was not present in these subjects.' l4 Kelley et al have reported widespread depressions of CBF and metabolism in patients with intracerebral hemorrhage." 5 A relative increase in rCMRO 2 in the area immediately adjacent to the hemorrhage was sometimes seen." 6 Volpe and co-workers have reported widespread changes in blood flow in premature infants with periventricular intracerebral hemorrhage." 7 They observed a two to four fold decrease in CBF throughout the affected hemisphere posterior and lateral to the intracerebral hematoma. In asphyxiated newborns, these same investigators have recently reported parasagittal decreases in rCBF consistent with watershed infarction." 8 Similar findings have been reported with 18 FDG in a neonate with bilateral subependymal hemorrhage and multiple hypoxic episodes." 9 
Conclusions
PET is still in its infancy. Only recently have radiotracer methods been developed to a sufficient degree to permit reliable, quantitative measurements of cerebral physiology under a wide variety of circumstances. There are still technical limitations and sources of error with all these methods that must be firmly kept in mind when interpreting the results of all clinical and experimental studies.
Since the pioneering work of Kety and Schmidt almost thirty years ago, 120 measurements of CBF in man by a variety of techniques have added a great deal to our understanding of the pathophysiology of cerebrovascular disease. Changes in CBF are, however, only part of the story. Studies with PET have already shown us that changes in blood flow are extremely variable, at times of uncertain clinical significance and difficult to interpret without concomitant information about metabolism and other physiologic variables. Further studies correlating clinical and radiographic data with quantitative regional measurements of cerebral physiology are needed. It is only by understanding the complex interaction among cerebral circulation, metabolism, and function that our knowledge of the pathophysiology of cerebrovascular disease can be advanced.
